$BUJA
Bukit Jalil Global Acquisition 1 Ltd.

2024 Q2 Form 10-Q Financial Statement

#000192998024000182 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $238.0K $232.7K $0.00
YoY Change 83.08%
Operating Profit -$238.0K -$232.7K -$57.00
YoY Change 83.89% 408119.3%
Interest Expense $789.8K $781.2K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $551.8K $548.5K $0.00
YoY Change -524.47%
Income Tax
% Of Pretax Income
Net Earnings $551.8K $548.5K $290.00
YoY Change -526.85% 189024.48%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.07 $0.07 $0.00
COMMON SHARES
Basic Shares Outstanding 7.762M shares 7.762M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.47K $31.51K $80.00K
YoY Change -91.99% -60.61%
Cash & Equivalents $54.47K $31.51K $83.44K
Short-Term Investments
Other Short-Term Assets $76.83K $118.1K $250.0K
YoY Change -35.98% -52.78%
Inventory
Prepaid Expenses $76.83K $118.1K
Receivables
Other Receivables
Total Short-Term Assets $131.3K $149.6K $340.0K
YoY Change -83.59% -56.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $61.46M $60.67M
YoY Change 5.3%
Other Assets
YoY Change
Total Long-Term Assets $61.46M $60.67M $0.00
YoY Change 5.3%
TOTAL ASSETS
Total Short-Term Assets $131.3K $149.6K $340.0K
Total Long-Term Assets $61.46M $60.67M $0.00
Total Assets $61.59M $60.81M $340.0K
YoY Change 4.1% 17786.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $199.0K $112.3K $10.00K
YoY Change 42.15% 1022.6%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $133.0K $0.00 $330.0K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $362.5K $142.8K $330.0K
YoY Change 141.69% -56.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.150M $1.150M
YoY Change 0.0%
Total Long-Term Liabilities $1.150M $1.150M $0.00
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $362.5K $142.8K $330.0K
Total Long-Term Liabilities $1.150M $1.150M $0.00
Total Liabilities $1.513M $1.293M $330.0K
YoY Change 16.35% 291.75%
SHAREHOLDERS EQUITY
Retained Earnings -$1.381M $0.00
YoY Change 836.65%
Common Stock $202.00 $202.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.381M $1.600M $6.786K
YoY Change
Total Liabilities & Shareholders Equity $61.59M $60.81M $340.0K
YoY Change 4.09% 17786.75%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $551.8K $548.5K $290.00
YoY Change -526.85% 189024.48%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$110.1K -$263.9K $70.00K
YoY Change -38.86% -476.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $18.13K
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 133.0K 0.000 20.00K
YoY Change -99.78% -100.0%
NET CHANGE
Cash From Operating Activities -110.1K -$263.9K 70.00K
Cash From Investing Activities 0.000 $0.00 $18.13K
Cash From Financing Activities 133.0K 0.000 20.00K
Net Change In Cash 22.95K -$263.9K 90.00K
YoY Change -96.11% -393.18%
FREE CASH FLOW
Cash From Operating Activities -$110.1K -$263.9K $70.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295372 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001956055
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Temporary Equity Share Subscriptions
TemporaryEquityShareSubscriptions
5750000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2011807 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2011807 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2011807 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
212153 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
212153 shares
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
1437500 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-41729
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
BUKIT JALIL GLOBAL ACQUISITION 1 LTD.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
31-1 Taman Miharja Phase 3B
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Jalan 3/93
CY2024Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
2 ½ Miles, Cheras
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Kuala Lumpur
CY2024Q1 dei Entity Address Country
EntityAddressCountry
MY
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55200
CY2024Q1 dei City Area Code
CityAreaCode
603
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
91339688
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7761807 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31508 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
118051 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
101684 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
149559 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
397056 usd
CY2024Q1 us-gaap Investments
Investments
60665385 usd
CY2023Q4 us-gaap Investments
Investments
59884239 usd
CY2024Q1 us-gaap Assets
Assets
60814944 usd
CY2023Q4 us-gaap Assets
Assets
60281295 usd
CY2024Q1 bukit Due To Related Party Current
DueToRelatedPartyCurrent
30524 usd
CY2023Q4 bukit Due To Related Party Current
DueToRelatedPartyCurrent
38676 usd
CY2024Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
112260 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
118920 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
142784 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
157596 usd
CY2024Q1 bukit Deferred Underwriters Discountnoncurrent
DeferredUnderwritersDiscountnoncurrent
1150000 usd
CY2023Q4 bukit Deferred Underwriters Discountnoncurrent
DeferredUnderwritersDiscountnoncurrent
1150000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1292784 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1307596 usd
CY2024Q1 us-gaap Temporary Equity Share Subscriptions
TemporaryEquityShareSubscriptions
5750000 shares
CY2024Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
57922252 usd
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
54526904 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2011807 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
202 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
202 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1599706 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4446593 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1599908 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4446795 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60814944 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60281295 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
232685 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
57 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-232685 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-57 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
347 usd
CY2024Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
781146 usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
548461 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
290 usd
CY2024Q1 bukit Weighted Average Ordinary Shares Outstanding Basic And Diluted
WeightedAverageOrdinarySharesOutstandingBasicAndDiluted
5750000 shares
CY2024Q1 bukit Earning Per Ordinary Shares Basic And Diluted
EarningPerOrdinarySharesBasicAndDiluted
0.22
CY2023Q1 bukit Earning Per Ordinary Shares Basic And Diluted
EarningPerOrdinarySharesBasicAndDiluted
0
CY2024Q1 bukit Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted
WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted
2011807 shares
CY2023Q1 bukit Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted
WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted
1250000 shares
CY2024Q1 bukit Basic And Diluted Net Loss Per Ordinary Share Attributable To Non Redeemable Ordinary Shares
BasicAndDilutedNetLossPerOrdinaryShareAttributableToNonRedeemableOrdinaryShares
-0.37
CY2023Q1 bukit Basic And Diluted Net Loss Per Ordinary Share Attributable To Non Redeemable Ordinary Shares
BasicAndDilutedNetLossPerOrdinaryShareAttributableToNonRedeemableOrdinaryShares
-0.01
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4446795 usd
CY2024Q1 bukit Accretion Of Ordinary Share Subject To Redemption Value
AccretionOfOrdinaryShareSubjectToRedemptionValue
-3395348 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
548461 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1599908 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6496 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
290 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
6786 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
548461 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
290 usd
CY2024Q1 bukit Dividend Income On Investments Held In Trust
DividendIncomeOnInvestmentsHeldInTrust
-781146 usd
CY2023Q1 bukit Dividend Income On Investments Held In Trust
DividendIncomeOnInvestmentsHeldInTrust
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
70278 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-16367 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2024Q1 bukit Increase Decrease In Due To Related Party Payable
IncreaseDecreaseInDueToRelatedPartyPayable
-8152 usd
CY2023Q1 bukit Increase Decrease In Due To Related Party Payable
IncreaseDecreaseInDueToRelatedPartyPayable
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-6660 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-5260 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-263864 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65308 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30492 usd
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
12358 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18134 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-263864 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
83442 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295372 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31508 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83442 usd
CY2024Q1 bukit Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
0 usd
CY2023Q1 bukit Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
5000 usd
CY2024Q1 bukit Accrued Expense Paid By Promissory Note Related Party
AccruedExpensePaidByPromissoryNoteRelatedParty
0 usd
CY2023Q1 bukit Accrued Expense Paid By Promissory Note Related Party
AccruedExpensePaidByPromissoryNoteRelatedParty
50000 usd
CY2024Q1 bukit Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
3395348 usd
CY2023Q1 bukit Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
0 usd
CY2023 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2024Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
7505226 usd
CY2024Q1 us-gaap Accretion Expense
AccretionExpense
2743134 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
548461 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
290 usd
CY2024Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
2011807 shares

Files In Submission

Name View Source Status
0001929980-24-000182-index-headers.html Edgar Link pending
0001929980-24-000182-index.html Edgar Link pending
0001929980-24-000182.txt Edgar Link pending
0001929980-24-000182-xbrl.zip Edgar Link pending
bukit-20240331.xsd Edgar Link pending
bukit_10q.htm Edgar Link pending
bukit_ex311.htm Edgar Link pending
bukit_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bukit-20240331_lab.xml Edgar Link unprocessable
bukit-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bukit_10q_htm.xml Edgar Link completed
bukit-20240331_cal.xml Edgar Link unprocessable
bukit-20240331_def.xml Edgar Link unprocessable